A "boots on the ground" report describes a patient's experience being pressured by a doctor to take Ozempic despite having healthy A1C levels. The discussion explores potential financial incentives for physicians to prescribe GLP-1 drugs for weight loss. The term "spiffs" is used to describe historical kickback schemes in other industries.
